Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-26
1997-01-21
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546163, A61K 3147, C07D21544, C07D21546
Patent
active
055960022
ABSTRACT:
Novel aminoquinoline derivatives of the general formula ##STR1## are described. Also described are methods for the treatment of malaria pathogens, particularly chloroquine-resistance malaria pathogens with compounds of formula I or the pharmaceutically acceptable salts and hydrolyzable esters thereof.
REFERENCES:
patent: 2594419 (1952-04-01), Geschickter
patent: 3346579 (1967-10-01), Sheehan
Singh, "Antimalarials . . . ", J Med Chem, vol. 14, No. 4, pp. 283-286, 1971.
Hofheinz Werner
Jaquet Catherine
Jolidon Syn ese
Hoffmann-La Roche Inc.
Ivy C. Warren
Johnston George W.
M. Mach D. Margaret
Rocha-Tramaloni Patricia S.
LandOfFree
Method of treating chloroquine-resistant malaria with aminoquino does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating chloroquine-resistant malaria with aminoquino, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating chloroquine-resistant malaria with aminoquino will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324398